Literature DB >> 35505020

Stereotaxic Implantation of F98 Cells in Fischer Rats: A Syngeneic Model to Investigate Photodynamic Therapy Response in Glioma.

Anne-Laure Bulin1, Jean-François Adam2, Hélène Elleaume2.   

Abstract

When investigating the promise of novel therapeutic modalities, the choice of an appropriate and reproducible in vivo model is critical to determine the relevance of the findings. In the case of glioblastoma, a high-grade glioma tumor that is clinically characterized by a high infiltrative pattern, no existing model exactly mimics the clinical features of these tumors. However, a syngeneic rat model of glioblastoma in which F98 cells are orthotopically implanted can recapitulate most of the characteristics of glioma as observed in patients, including a highly aggressive nature, a high degree of infiltration of cancer cells into healthy tissue, and a strong resistance to commonly used treatments including radiotherapy and chemotherapy. Here, we provide a detailed protocol to stereotaxically implant F98 cells in the rat brain and obtain a reproducible and clinically representative glioma model in rodents.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  F98 glioma; Glioblastoma; Photodynamic therapy; Radiation therapy; Rodent models of cancer; Stereotaxic implantation

Mesh:

Year:  2022        PMID: 35505020     DOI: 10.1007/978-1-0716-2099-1_15

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  9 in total

Review 1.  Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.

Authors:  Jonathan P Celli; Bryan Q Spring; Imran Rizvi; Conor L Evans; Kimberley S Samkoe; Sarika Verma; Brian W Pogue; Tayyaba Hasan
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 2.  Photodynamic therapy and anti-tumour immunity.

Authors:  Ana P Castano; Pawel Mroz; Michael R Hamblin
Journal:  Nat Rev Cancer       Date:  2006-07       Impact factor: 60.716

3.  Standardization and detailed characterization of the syngeneic Fischer/F98 glioma model.

Authors:  David Mathieu; Roger Lecomte; Ana Maria Tsanaclis; Annie Larouche; David Fortin
Journal:  Can J Neurol Sci       Date:  2007-08       Impact factor: 2.104

4.  Synchrotron radiation therapy of malignant brain glioma loaded with an iodinated contrast agent: first trial on rats bearing F98 gliomas.

Authors:  Jean François Adam; Hélène Elleaume; Aurélie Joubert; Marie Claude Biston; Anne Marie Charvet; Jacques Balosso; Jean François Le Bas; François Estève
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-12-01       Impact factor: 7.038

5.  Assessment of blood volume, vessel size, and the expression of angiogenic factors in two rat glioma models: a longitudinal in vivo and ex vivo study.

Authors:  Samuel Valable; Benjamin Lemasson; Régine Farion; Marine Beaumont; Christoph Segebarth; Chantal Remy; Emmanuel L Barbier
Journal:  NMR Biomed       Date:  2008-11       Impact factor: 4.044

6.  An improved rat brain-tumor model.

Authors:  N Kobayashi; N Allen; N R Clendenon; L W Ko
Journal:  J Neurosurg       Date:  1980-12       Impact factor: 5.115

7.  Stereotaxic implantation of dispersed cell suspensions into brain. A systematic appraisal of cell placement and survival.

Authors:  R J Plunkett; R J Weber; E H Oldfield
Journal:  J Neurosurg       Date:  1988-08       Impact factor: 5.115

8.  Photoactivation of gold nanoparticles for glioma treatment.

Authors:  Laure Bobyk; Magali Edouard; Pierre Deman; Mathias Vautrin; Karin Pernet-Gallay; Julie Delaroche; Jean-François Adam; François Estève; Jean-Luc Ravanat; Hélène Elleaume
Journal:  Nanomedicine       Date:  2013-05-01       Impact factor: 5.307

9.  Intracerebral delivery of carboplatin in combination with either 6 MV photons or monoenergetic synchrotron X-rays are equally efficacious for treatment of the F98 rat glioma.

Authors:  Laure Bobyk; Magali Edouard; Pierre Deman; Julia Rousseau; Jean-François Adam; Jean-Luc Ravanat; François Estève; Jacques Balosso; Rolf F Barth; Hélène Elleaume
Journal:  J Exp Clin Cancer Res       Date:  2012-09-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.